Consistently, we found that Eomes+CD4+ T cells were remarkably increased in the peripheral blood and cerebrospinal fluid (CSF) of SPMS patients, compared with healthy subjects and patients with RRMS. The gene discussed is CD4; the disease is secondary progressive multiple sclerosis.